Patriot Financial Group Insurance Agency, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Patriot Financial Group Insurance Agency, LLC

  • $621 Million
  • Q1 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
SELL
$27.79 - $50.61 $583 - $1,062
-21 Reduced 17.8%
97 $3,000
Q1 2022

May 11, 2022
SELL
$39.62 - $69.97 $673 - $1,189
-17 Reduced 12.59%
118 $5,000
Q4 2021

Jan 10, 2022
BUY
$58.09 - $82.51 $290 - $412
5 Added 3.85%
135 $9,000
Q3 2021

Nov 24, 2021
BUY
$58.38 - $84.96 $1,050 - $1,529
18 Added 16.07%
130 $8,000
Q1 2021

Apr 29, 2021
SELL
$61.35 - $90.47 $736 - $1,085
-12 Reduced 9.68%
112 $7,000
Q1 2020

Apr 15, 2020
BUY
$20.56 - $63.12 $2,549 - $7,826
124 New
124 $4,000

Others Institutions Holding ARWR

# of Institutions
296
Shares Held
88.5M
Call Options Held
905K
Put Options Held
387K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.71B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email